業績一覧

2020年 業績

ベーチェット病診療ガイドライン2020.日本ベーチェット病学会監修. 厚生労働科学研究費補助金(難治性疾患政策研究事業)ベーチェット病に関する調査研究班、厚生労働科学研究費補助金(難治性疾患政策研究事業)難治性炎症性両障害に関する調査研究班編集、水木信久、竹内正樹責任編集.東京、診断と治療社、2020

Tsutsui H, Kikuchi H, Oguchi H, Nomura K, Ohkubo T. Identification of Physical and Psychosocial Problems Based on Symptoms in Patients With Behçet's Disease. Rheumatol Int.;40:81-89. 2020 Jan.

Sakurai Y, Takayama K, Abe T, Takeuchi M:
Chronic chorioretinal detachment under normal intraocular pressure in eye with uveitic glaucoma after trabeculectomy: A case report. Medicine (Baltimore). 99(2):e18652. 2020 Jan.

Kunimi K, Usui Y, Tsubota K, Mitsuhashi R, Umazume A, Kezuka T, Sakai J, Goto H.
Changes in Etiology of Uveitis in a Single Center in Japan. Ocul Immunol Inflamm. 18:1-6. doi: 10.1080/09273948.2019.1709649. 2020 Feb.

Riahi P, Kazemnejad A, Mostafaei S, Meguro A, Mizuki N, Ashraf-Ganjouei A, Javinani A, Faezi ST, Shahram F, Mahmoudi M: ERAP1 polymorphisms interactions and their association with Behçet’s disease susceptibly: Application of Model-Based Multifactor Dimension Reduction Algorithm (MB-MDR). PLoS One. 15(2): e0227997, 2020.Feb.

Fukunaga H, Kaburaki T, Shirahama S, Tanaka R, Murata H, Sato T, Takeuchi M, Tozawa H, Urade Y, Katsura M, Kobayashi M, Wada Y, Soga H, Kawashima H, Kohro T, Aihara M:
Analysis of inflammatory mediators in the vitreous humor of eyes with pan-uveitis according to aetiological classification. Sci Rep. 10(1):2783.2020 Feb.

Nakahara H, Kaburaki T, Tanaka R, Yoshida A, Takamoto M, Kawata M, Fujino Y, Kawashima H, Aihara M. Comparisons of Clinical Features in Japanese Patients with Behçet's Uveitis Treated in the 1990s and the 2000s. Ocul Immunol Inflamm. ;28(2):262-269. doi: 10.1080/09273948.2018.1559928.2020

Takeno M. Positioning of apremilast in treatment of Behcet's disease. Mod Rheumatol. ;30(2):219-224. 2020 Mar.

Nakamura K, Iwata Y, Asai J, Kawakami T, Tsunemi Y, Takeuchi M, Mizuki N, Kaneko F; Members of the Consensus Conference on Treatment of Skin and Mucosal Lesions (Committee of Guideline for the Diagnosis and Treatment of Mucocutaneous Lesions of Behçet's disease). Guidelines for the treatment of skin and mucosal lesions in Behcet's disease: A secondary publication.J Dermatol. ; 47(3): 223-235. 2020 Mar.

Kaburaki T, Fukunaga H, Tanaka R, Nakahara H, Kawashima H, Shirahama S, Izawa H, Komae K, Takamoto M, Soga H, Aihara M. Retinal vascular inflammatory and occlusive changes in infectious and non-infectious uveitis. Jpn J Ophthalmol. ;64(2):150-159. 2020 Mar.

Kitano M, Tanaka R, Kaburaki T, Nakahara H, Shirahama S, Suzuki T, Komae K, Aihara M. Clinical Features and Visual Outcome of Uveitis in Japanese Patients Younger than 18 Years. Ocul Immunol Inflamm. 12:1-7. Online ahead of print. 2020 Mar.

Watanabe K, Tanida S, Inoue N, Kunisaki R, Kobayashi K, Nagahori M, Arai K, Uchino M, Koganei K, Kobayashi T, Takeno M, Ueno F, Matsumoto T, Mizuki N, Suzuki Y, Hisamatsu T. Evidence-based diagnosis and clinical practice guidelines for intestinal Behçet's disease 2020 edited by Intractable Diseases, the Health and Labour Sciences Research Grants. J Gastroenterol. ;55(7):679-700. 2020 Jul.

Mizuki Y, Horita N, Horie Y, Takeuchi M, Ishido T, Mizuki R, Kawagoe T, Shibuya E, Yuda K, Ishido M, Minegishi K, Yoshimi R, Kirino Y, Kato S, Arimoto J, Fukumoto T, Kurosawa M, Kitaichi N, Takeno M, Kaneko T, Mizuki N. The influence of HLA-B51 on clinical manifestations among Japanese patients with Behçet's disease: A nationwide survey. Mod Rheumatol. ;30(4):708-714. 2020 Jul.

Hayashida M, Miyoshi J, Mitsui T, Miura M, Saito D, Sakuraba A, Kawashima S, Ikegaya N, Fukuoka K, Karube M, Komagata Y, Kaname S, Okada AA, Fujimori S, Matsuura M, Hisamatsu T. Elevated fecal calprotectin and lactoferrin are associated with small intestinal lesions in patients with Behçet disease. J Gastroenterol Hepatol. ;35(8):1340-1346. 2020 Aug.

Kunimi K, Usui Y, Asakage M, Maehara C, Tsubota K, Mitsuhashi R, Umazume A, Kezuka T, Sakai J, Goto H. Anti-TNF-α therapy for refractory uveitis associated with Behçet's Syndrome and sarcoidosis: a single center study of 131 patients
Ocul Immunol Inflamm. 2020 Aug.

Balt J, Jamyanjav B, Jav S, Dandii Z, Ganbold C, Horie Y, Lenikov A, Zhang A, Uehara O, Ohno S, Kitaichi N. Clinical features of Behcet’s disease in Mongolia: A multicenter study. Clin Rheumatol. ; 39: 2697-2706 .2020 Sep.

Balt J, Uehara O, Abiko Y, Jamyanjav B, Jav S, Nagasawa T, Horie Y, Mori M, Fujita M, Lennikov A, Ohta T, Hiraoka M, Iwata D, Namba K, Ohno S, Kitaichi N. Alteration of oral flora in Mongolian patients with Behcet’s disease – A multicenter study. Clin Exp Rheumatol.; 127: 80-85 .2020 Sep.

Hirohata S, Kikuchi H, Sawada T, Okada M, Takeno M, Kuwana M, Kawachi I, Mochizuki H, Kusunoki S, Ishigatsubo Y. Recommendations for the Management of Neuro-Behçet's Disease by the Japanese National Research Committee for Behçet's Disease. Intern Med. 59(19): 2359-2367, 2020 Oct.

Shirahama S, Kaburaki T, Matsuda J, Tanaka R, Nakahara H, Komae K, Kawashima H, Aihara M. The Relationship between Fluorescein Angiography Leakage after Infliximab Therapy and Relapse of Ocular Inflammatory Attacks in Ocular Behçet's Disease Patients. Ocul Immunol Inflamm.;28(8):1166-1170. 2020 Nov.

Suhler EB, Jaffe GJ, Fortin E, Lim LL, Merrill PT, Dick AD, Brezin AP, Nguyen QD, Thorne JE, Van Calster J, Cimino L, Adan A, Goto H, Kaburaki T, Kramer M, Vitale AT, Kron M, Song AP, Liu J, Pathai S, Douglas KM, Schlaen A, Muccioli C, Van Velthoven MEJ, Zierhut M, Rosenbaum JT. Long-Term Safety and Efficacy of Adalimumab in Patients With Noninfectious Intermediate Uveitis, Posterior Uveitis, or Panuveitis. Ophthalmology.:S0161-6420(20)31038-1.2020 Nov.

Shimizu H, Usui Y, Asakage M, Nezu N, Wakita R, Tsubota K, Sugimoto M, Goto H. Serum metabolomic profiling of patients with non-infectious uveitis. J Clin Med. 9: E3955, 2020 Dec.

このページのトップへ戻る